Quincey James insider trades
Quincey James has filed 57 Form 4s with the SEC that we hold, for Coca Cola Co (KO) (Chairman, Director) and Pfizer INC (PFE) (Director). Across all of them we count 0 purchases worth $0 and 28 sales worth $233.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 8 sales ($144.7M). The largest single trade was a sale of 436,296 shares of Coca Cola Co worth $35.0M, dated 2026-06-05. The first filing on our record is dated 2021-07-06 and the latest 2026-09-29.
Coca Cola Co (KO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-07-28 | S, sale reported on Form 4 | 32,000 | $2.1M | 2022-07-29 |
| 2023-02-13 | S, sale reported on Form 4 | 34,875 | $2.1M | 2023-02-15 |
| 2023-03-07 | S, sale reported on Form 4 | 46,421 | $2.8M | 2023-03-09 |
| 2023-05-01 | S, sale reported on Form 4 | 150,000 | $9.6M | 2023-05-02 |
| 2023-09-18 | S, sale reported on Form 4 | 92,029 | $5.3M | 2023-09-20 |
| 2023-10-17 | S, sale reported on Form 4 | 92,029 | $5.0M | 2023-10-19 |
| 2023-11-16 | S, sale reported on Form 4 | 92,028 | $5.3M | 2023-11-20 |
| 2023-12-18 | S, sale reported on Form 4 | 92,028 | $5.4M | 2023-12-20 |
| 2024-02-22 | S, sale reported on Form 4 | 247,188 | $15.1M | 2024-02-26 |
| 2024-08-21 | S, sale reported on Form 4 | 36,232 | $2.5M | 2024-08-23 |
| 2024-08-21 | S, sale reported on Form 4 | 22,073 | $1.5M | 2024-08-23 |
| 2024-08-21 | S, sale reported on Form 4 | 22,114 | $1.5M | 2024-08-23 |
| 2024-08-21 | S, sale reported on Form 4 | 22,114 | $1.5M | 2024-08-23 |
| 2024-08-26 | S, sale reported on Form 4 | 14,160 | $991.6K | 2024-08-27 |
| 2024-08-26 | S, sale reported on Form 4 | 14,119 | $988.8K | 2024-08-27 |
| 2024-08-26 | S, sale reported on Form 4 | 14,118 | $988.3K | 2024-08-27 |
| 2024-11-08 | S, sale reported on Form 4 | 100,000 | $6.4M | 2024-11-12 |
| 2025-02-25 | S, sale reported on Form 4 | 145,435 | $10.3M | 2025-02-27 |
| 2025-05-30 | S, sale reported on Form 4 | 66,600 | $4.8M | 2025-06-03 |
| 2025-05-30 | S, sale reported on Form 4 | 66,601 | $4.8M | 2025-06-03 |
| 2026-02-03 | S, sale reported on Form 4 | 337,824 | $26.0M | 2026-02-05 |
| 2026-03-03 | S, sale reported on Form 4 | 688 | $54.4K | 2026-03-05 |
| 2026-03-03 | S, sale reported on Form 4 | 250,000 | $19.8M | 2026-03-05 |
| 2026-05-07 | S, sale reported on Form 4 | 200,000 | $15.8M | 2026-05-11 |
| 2026-06-04 | S, sale reported on Form 4 | 8,000 | $640.0K | 2026-06-08 |
| 2026-06-05 | S, sale reported on Form 4 | 436,296 | $35.0M | 2026-06-08 |
| 2026-07-28 | S, sale reported on Form 4 | 381,140 | $34.3M | 2026-07-30 |
| 2026-07-29 | S, sale reported on Form 4 | 145,947 | $13.1M | 2026-07-30 |
Pfizer INC (PFE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1561264) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms